Aktie SKINVISIBLE INC
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Skinvisible Inc OTC Bulletin Board

Aktien

US8307031042

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Skinvisible, Inc. announced that it has received $0.035 million in funding
Skinvisible, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Skinvisible, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome
Skinvisible, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Skinvisible, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Skinvisible, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Skinvisible, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)
Skinvisible, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)
Skinvisible, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)
Skinvisible, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Skinvisible, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Skinvisible, Inc. Auditor Raises 'Going Concern' Doubt
SKINVISIBLE, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PBMF Aktie
  4. Aktie
  5. Nachrichten Skinvisible Inc
  6. Andere Sprachen